The agreement fulfills several…
The agreement fulfills several ambitions for UCB. Besides building its [...]
More than a year after licensing…
More than a year after licensing its PD-1xVEGF bispecific, Merck [...]
Following its recently announced…
Following its recently announced partnership with Novo Nordisk, OpenAI is [...]
Kailera Therapeutics appears to…
Kailera Therapeutics appears to have set a new benchmark for [...]
After helping guide Metsera…
After helping guide Metsera through its high-profile, $10 billion acquisition [...]
After its bet on a rare eye…
After its bet on a rare eye disease gene therapy [...]
Storm Therapeutics has closed a…
Storm Therapeutics has closed a $56 million series C financing [...]
Aligos Therapeutics has secured a…
Aligos Therapeutics has secured a $25 million upfront fee from [...]
The Spanish government has…
The Spanish government has announced a goal to raise a [...]
The steady stream of IPOs…
The steady stream of IPOs evaporated almost as quickly as [...]